OralDNA to Distribute Periodontal Disease Genetic Test in US - DNA at the Dentist's Office

Dentists now are coming in to the fold of DNA genomics tests. This test is very specific to assess risk for periodontal disease, so as a younger patient, as chances are as we age if we are at risk we may already have this, this could be a good indicator for the dentist to have in the knowledge bank to be aware that you could possibly be a strong candidate for developing the disease.

As biotech continues to grow in many areas, who's going to want have your DNA, it is still a choice by the end consumer, but as you can see our DNA someday could be stockpiled in more than one place. BD

NEW YORK (GenomeWeb News) OralDNA Labs has licensed the rights to sell an Interleukin Genetics test that assesses the risk for periodontal disease, Interleukin said Wednesday. Under the agreement, the oral diagnostics company has acquired a non-exclusive license allowing it to market, sell, and distribute Interleukin Genetics PST Genetic Test to dental practices in the US.